203 related articles for article (PubMed ID: 12838707)
1. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
Han B; Li L; Wang H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation proteins and aggressiveness of histological variants of ameloblastoma and keratocystic odontogenic tumor.
Gupta K; Chaturvedi TP; Gupta J; Agrawal R
Biotech Histochem; 2019 Jul; 94(5):348-351. PubMed ID: 30806083
[TBL] [Abstract][Full Text] [Related]
3. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor.
Metgud R; Gupta K
Ann Diagn Pathol; 2013 Dec; 17(6):518-21. PubMed ID: 24090509
[TBL] [Abstract][Full Text] [Related]
5. [Expression of P27 protein in odontogenic tumors].
Wang L; Lu Y; Wu L; Wei Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 1998 Feb; 16(1):10-1. PubMed ID: 12078170
[TBL] [Abstract][Full Text] [Related]
6. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
7. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
[TBL] [Abstract][Full Text] [Related]
8. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
9. Histochemistry of Ki-67 antigen in ameloblastomas.
Nagao Y; Wato M; Tanaka A
J Osaka Dent Univ; 1999 Oct; 33(2):53-7. PubMed ID: 10863475
[TBL] [Abstract][Full Text] [Related]
10. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
11. [Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma].
Liu J; Wang S; Chen X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):62-4. PubMed ID: 11955366
[TBL] [Abstract][Full Text] [Related]
12. Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma.
Ahlem B; Wided A; Amani L; Nadia Z; Amira A; Faten F
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Nov; 132(5):275-9. PubMed ID: 26386615
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
[TBL] [Abstract][Full Text] [Related]
14. A immunohistochemical study of the peripheral ameloblastoma.
Kishino M; Murakami S; Yuki M; Iida S; Ogawa Y; Kogo M; Toyosawa S
Oral Dis; 2007 Nov; 13(6):575-80. PubMed ID: 17944675
[TBL] [Abstract][Full Text] [Related]
15. P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas.
Florescu A; Simionescu C; Ciurea R; Pitru A
Rom J Morphol Embryol; 2012; 53(1):105-9. PubMed ID: 22395508
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
18. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report.
Jivan V; Altini M; Meer S; Mahomed F
Head Neck Pathol; 2007 Dec; 1(2):146-9. PubMed ID: 20614266
[TBL] [Abstract][Full Text] [Related]
19. The expression of NF-kappaB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC.
Gong Y; Wang L; Wang H; Li T; Chen X
Oral Oncol; 2009 Jun; 45(6):515-20. PubMed ID: 18723387
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Ribeiro BF; Iglesias DP; Nascimento GJ; Galvão HC; Medeiros AM; Freitas RA
Oral Dis; 2009 Oct; 15(7):472-7. PubMed ID: 19522745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
